Ontology highlight
ABSTRACT:
SUBMITTER: Crooke ST
PROVIDER: S-EPMC8005817 | biostudies-literature | 2021 Jan-Jun
REPOSITORIES: biostudies-literature
Crooke Stanley T ST Liang Xue-Hai XH Baker Brenda F BF Crooke Rosanne M RM
The Journal of biological chemistry 20210101
Antisense technology is beginning to deliver on the broad promise of the technology. Ten RNA-targeted drugs including eight single-strand antisense drugs (ASOs) and two double-strand ASOs (siRNAs) have now been approved for commercial use, and the ASOs in phase 2/3 trials are innovative, delivered by multiple routes of administration and focused on both rare and common diseases. In fact, two ASOs are used in cardiovascular outcome studies and several others in very large trials. Interest in the ...[more]